Fosamprenavir Calcium Tablet, Film Coated
Product Images NDC 0378-3520

3 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosamprenavir Calcium (NDC 0378-3520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fosamprenavir Structural Formula (Image 01)

Fosamprenavir Structural Formula (Image 01)
Chemical structure of fosamprenavir calcium showing the molecular arrangement including phenyl groups, phosphate, sulfonamide, and calcium ion (Ca2+) associated with the molecule.*
FDA Label Image

Figure 1. Mean (±sd) Steady-state Plasma Amprenavir Concentrations And Mean Ec50 Values Against Hiv From Protease Inhibitor-naive Subjects (in The Absence Of Human Serum) (Image 02)

Figure 1. Mean (±sd) Steady-state Plasma Amprenavir Concentrations And Mean Ec50 Values Against Hiv From Protease Inhibitor-naive Subjects (in The Absence Of Human Serum) (Image 02)
A pharmacokinetic graph showing plasma amprenavir concentration (mcg/mL) over 24 hours after dosing with various fosamprenavir regimens, including 1,400 mg once daily plus ritonavir 200 mg once daily, 700 mg twice daily plus ritonavir 100 mg twice daily, 1,400 mg twice daily, and 1,400 mg once daily plus ritonavir 100 mg once daily. The graph includes mean concentrations with error bars and an EC50 reference line for wild-type virus.*
FDA Label Image

Fosamprenavir Calcium Tablets 700 mg Bottle Label (Image 03)

Fosamprenavir Calcium Tablets 700 mg Bottle Label (Image 03)
Fosamprenavir Calcium Tablets 700 mg film-coated tablets label from Mylan Pharmaceuticals Inc. The label includes dosage strength, a red alert box warning about drug interactions, NDC 0378-3520-91, formulation details, storage instructions, manufacturer information, barcode, and packaging for 60 tablets with prescription-only indication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.